Göran Ando | MD

Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]

Genghis Lloyd-Harris | MD, PhD

Genghis identifies and invests in new businesses and supports portfolio companies. He focuses on exits of venture investments via mergers and acquisitions and IPOs. Genghis’ current and past [...]

Andrew Jefferson | MBA

Andrew is an Operating Partner at Versant Ventures and has been the Chief Operating Officer at Ridgeline Discovery since 2018. Ridgeline is Versant’s Discovery Engine which creates and operates [...]

Joachim (JR) Rothe | PhD

Joachim joined LSP in 2002 and is currently a Managing Partner and co-owner of the firm. His prime focus and responsibility within LSP is to invest in unlisted securities and the general [...]

Scott Rocklage | PhD

Scott joined 5AM Ventures in 2003 as a Venture Partner and became a Managing Partner in 2004. He has over three decades of healthcare management experience with strategic leadership [...]

Marina Udier | PhD

Marina joined Nouscom in 2016 as the Chief Operating Officer from Versant Ventures where she was an Operating Principal. Prior to Versant, Marina was at Novartis Pharma in Basel in various senior [...]

Sofia Ioannidou | PHD

Sofia joined Andera Partners in 2009 and is currently a Partner in the Andera Life Sciences team. Prior to Andera Partners, Sofia was part of the Life Sciences team of L.E.K. Consulting London [...]

Thibaut Roulon | PHD

Thibaut joined Bpifrance in 2010 and is currently Senior Investment Director. He has more than 15 years of experience in Life Science investments. Thibaut started his career as a Scientist in a [...]

John F. McDonald | JD, MBA

John has over 25 years of business development experience with some of the industry’s premier companies, including Genentech, Genzyme, Millennium Pharmaceuticals, MPM Capital, Biogen and [...]

Hakan Goker | PHD

Hakan Goker, PhD, is Managing Director of M Ventures and heads the Biotechnology investments covering Healthcare and Life Sciences. Hakan joined M Ventures in 2013 and has been investing in the [...]

page 1 of 2